- Home
- Products
- Customized FluoroAb™
- CD40LG
- Toralizumab-Bodipy FL
Toralizumab-Bodipy FL (CAT#: ADC-FL-804)
- TARGET
- ANTIBODY
- DYE
- Name
- CD40LG
- Alternative Names
- CD40LG; CD40 ligand; HIGM1, IMD3, TNFSF5, tumor necrosis factor (ligand) superfamily, member 5 (hyper IgM syndrome); CD40 antigen ligand; CD40L; CD154; gp39; hCD40L; hyper IgM syndrome; T B cell activating molecule; TNF related activation protein; TRAP; internalized inside cells, the cytosol provides reducing environment including intracellular enzyme protein disulfide isomerase, or similar enzymes, drugs can be released.
- Overview
- The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome.
- Overview
- Humanized Anti-CD40L IgG1-kappa antibody, Toralizumab
- Generic name
- Toralizumab
- Species Reactivity
- Human
- Name
- Bodipy FL
- Color
- Green
- Excitation⁄Emission (nm)
- 503/512
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-804. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-2448 | Anti-CD40LG (Dapirolizumab pegol)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-921 | Anti-CD40LG (Toralizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-920 | Anti-CD40LG (Toralizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-2446 | Anti-CD40LG (Dapirolizumab pegol)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-917 | Anti-CD40LG (Ruplizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ITGB2 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2189)
- Anti-CD19 MAb (Clone 28)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2472)
- Anti-SOST MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2231)
- Anti-C5 MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2120)
- Anti-CD4 MAb (Clone 33)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8856)
- Tregalizumab-iFluor 680 (CAT#: ADC-FL-676)
- Anti-BSG MAb (Clone 4)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4742)
- Ontuxizumab-Cy5 (CAT#: ADC-FL-483)
- Anti-HBV MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS740)
- Anti-CD79B MAb (Clone 1)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS4852)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
